Article
Presented by John A. Libertino, MD, Lahey Clinic, Burlington, MA
Study characterizes long-term impact of prostate cancer treatment
Key updates from the AUA/ASRM male infertility guideline amendment
Phase 1/2 trial of ONCT-534 in mCRPC has been terminated
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Genomic risk model validated for prostate cancer risk prediction
Expert roundtables focus on upper tract urothelial carcinoma